loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers for 85883 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ACETAMINOPHEN; CODEINE PHOSPHATE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : CAPITAL AND CODEINE

Ireland
Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : CAPITAL AND CODEINE

Ireland
arrow
Boulder Peptide 2024
Not Confirmed

Actavis Inc

Dosage Form : SUSPENSION;ORAL

Brand Name : CAPITAL AND CODEINE

Dosage Strength : 120MG/5ML;12MG/5ML

Packaging :

Approval Date : 1982-01-01

Application Number : 85883

Regulatory Info : DISCN

Registration Country : USA

blank